Results 101 to 110 of about 17,623 (223)

Hyperandrogenism and Obesity: Ominous Co-Morbidities

open access: yes, 2009
This review has a two-fold objective. One, it addresses the association of hyperandrogenism and obesity and the complex metabolic derangements that are part of the problem. Clinical management of these co-morbidities is challenging and complex.
Goodwin, Amanda J.   +3 more
core  

hyperandrogenism in polycystic ovary syndrome

open access: yesمجلة كلية الطب, 2006
Background:
malka S. Al- saadi
doaj  

Assessment of hormone measurement methods in girls with premature adrenarche, polycystic ovary syndrome, and non-classical congenital adrenal hyperplasia

open access: yesThe Turkish Journal of Pediatrics
Introduction. Hyperandrogenism is a clinical condition in girls, resulting from excessive androgen production originating from the adrenal glands or ovaries.
Mert Uçar   +8 more
doaj   +1 more source

Hyperandrogenism in post-menopausal women [PDF]

open access: yes, 2019
Η εμμηνόπαυση είναι η περίοδος στη ζωή της γυναίκας η οποία χαρακτηρίζεται από τη μόνιμη διακοπή της εμμηνόρροιας και που σχετίζεται με ορμονικές αλλαγές εκ των οποίων η πιο σημαντική είναι η μείωση των οιστρογόνων.
Kostakis Ervin   +1 more
core  

Hyperandrogenism in postmenopausal women

open access: yes, 2017
Androgeny u kobiet odgrywają ważną rolę. Regulują metabolizm, wpływając na nastrój czy funkcje seksualne. Jednakże ich nadmiar działa negatywne na zdrowie kobiet.
Świątkowska-Stodulska, Renata; Department of Endocrinology and Internal Medicine, Medical University of Gdansk, Gdansk   +3 more
core  

Pure Leydig cell tumor of the ovary: a rare presentation of a rare entity in a pregnant patient

open access: yesFuture Science OA
Aim: Leydig cell tumors (LCT) are rare neoplasms that represent less than 0.1% of all ovarian tumors. This tumor usually presents with signs and symptoms of excess androgen levels. Diagnosis is made based on a combination of history, laboratory findings,
Anwar Rjoop   +4 more
doaj   +1 more source

ABILITY TO RESTORE REPRODUCTIVE SYSTEM IN PATHINTS WITH COMBINED FORM OF HYPERANDROGENISM

open access: yes, 2016
Combined form of hyperandrogenism is one of the leading pathogenic causes of menstrual and reproductive disfunctions. Anovulation state causes an increase in the level of the main androgens, and the luteal phase deficiency is a consequence of the ...
R. A. Saidova   +2 more
core   +1 more source

Hyperandrogen-induced imbalance of FOXO4-AR regulatory loop contributes to ovulatory disorders in polycystic ovary syndrome

open access: yesMolecular Therapy: Nucleic Acids
Polycystic ovary syndrome (PCOS) is the leading cause of anovulatory infertility, and its underlying mechanisms remain largely unknown. Our study aimed to investigate the role of FOXO4 in PCOS and its possible regulatory mechanisms.
Ruiqiong Zhou   +7 more
doaj   +1 more source

Hyperandrogenism as a side effect of anticonvulsants

open access: yes, 2018
Aim: confirm the connection between hyperandrogenism and side effects of antiepileptic drugs in women. Materials andMethods. Body weight, the menstrual cycle periodicity and the blood concentration of dihydrotestosterone were monitored in 278 women ...
V. O. Generalov   +2 more
core   +1 more source

Exploring the Predictive Role of 11‐Oxyandrogens in Diagnosing Polycystic Ovary Syndrome

open access: yesEndocrinology, Diabetes & Metabolism
Context Hyperandrogenism is a hallmark of polycystic ovary syndrome (PCOS), yet the androgen(s) responsible remain ambiguous. Recent studies have suggested that 11‐oxygenated C19 steroids (11‐oxyandrogens), specifically 11‐ketotestosterone, may be a good
Armaiti Parvez Mody   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy